S-1203586-72-4 | Cyclotraxin B acetate | (3S,6R,11R,17S,20S,23S,26S,32S,35S)-6-amino-20-(4-aminobutyl)-3-(2-amino-2-oxoethyl)-17-(2-carboxyethyl)-23-[(1R)-1-hydroxyethyl]-26-[(4-hydroxyphenyl)methyl]-32-(2-methylsulfanylethyl)-2,5,13,16,19,22,25,28,31,34-
Product Description
Cyclotraxin B, a cyclic peptide, is a highly potent and selective TrkB inhibitor without altering the binding of BDNF. Cyclotraxin B non-competitively inhibits BDNF-induced TrkB activity with an IC50 of 0.30 nM. Cyclotraxin B can crosse the blood-brain-barrier and has analgesic and anxiolytic-like behavioral effects。
Specifications & Purity
≥98%
Biochemical and Physiological Mechanisms
Antagonist of TrkB receptors; inhibits BDNF-induced TrkB activity (IC50= 0.30 nM). Allosterically alters TrkB receptor conformation but does not alter BDNF binding. Prevents BDNF-induced cold allodynia in mice. Also shown to exhibit putative anxiolytic pr
Sequence
CNPMGYTKEGC(Modifications: Disulfide bridge between 1 - 11)
AI Insight
Product Specifications
Storage Temp
Store at -20°C,Argon charged
Shipped In
Ice chest + Ice pads
CAS
1203586-72-4
Certificates(CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Find and download the COA for your product by matching the lot number on the packaging.